HK2 and cervical cancer: Previous studies have also found that cervical cancer cells can reprogram cellular metabolic pathways so that these cervical cancer cells can benefit from increased expression of hexokinase 2, providing metabolites and intermediates of tricarboxylic acids for their growth [18].